IPO Itemizing on July 21: Anthem Biosciences Restricted will make its debut on NSE (Nationwide Inventory Alternate) and BSE (Bombay Inventory Alternate) on Monday, July 21. Anthem Biosciences IPO allotment finalised final week. The three-day subscription for Anthem Biosciences IPO was opened on July 14 (Monday) and closed on July 16 (Wednesday). On the closing day of the bidding, the preliminary public supply of Anthem Biosciences Ltd subscribed 63.86 instances.
ARTICLE CONTINUES BELOW VIDEO
Anthem Biosciences IPO Subscription
The preliminary share sale acquired bids for two,81,44,34,740 shares towards 4,40,70,682 shares on supply, in line with NSE knowledge. The portion for certified institutional patrons (QIBs) fetched a whopping 182.65 instances subscription. The non-institutional traders half obtained subscribed 42.35 instances, and retail particular person traders (RIIs) acquired a 5.64 instances subscription.
Anthem Biosciences IPO Worth Band
Anthem Biosciences IPO has fastened the worth band at Rs 540 to Rs 570 per fairness share.
Anthem Biosciences IPO Registrar
KFin Applied sciences Restricted is the registrar of Anthem Biosciences IPO.
Anthem Biosciences IPO Face Worth, Tick Measurement
The face worth and tick measurement of Anthem Biosciences IPO is Rs 2 and Re 1, respectively.
Anthem Biosciences IPO Itemizing Date
Anthem Biosciences Restricted’s shares are proposed to be listed on NSE, and BSE. The itemizing will seemingly happen on July 21.
Anthem Biosciences IPO E-book Working Lead Managers
JM Monetary Restricted, Citigroup International Markets India Personal Restricted, J.P. Morgan India Personal Restricted and Nomura Monetary Advisory and Securities (India) Personal Restricted are the e book operating lead managers for the Anthem Biosciences IPO.
Story continues beneath this advert
Anthem Biosciences IPO Sponsor Financial institution
HDFC Financial institution Restricted and ICICI Financial institution Restricted are the sponsor banks for the Anthem Biosciences IPO.
About Anthem Biosciences Restricted
Anthem is into innovation-driven and technology-focused Contract Analysis, Improvement and Manufacturing Group (CRDMO) with totally built-in operations spanning throughout drug discovery, improvement and manufacturing. It additionally manufactures and sells advanced, specialised fermentation-based Lively Pharmaceutical Elements (APIs), together with probiotics, enzymes, peptides, dietary actives, vitamin analogues and biosimilars.
(With inputs from PTI)
© IE On-line Media Companies Pvt Ltd